サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768951

エクソソーム研究製品の世界市場

Exosome Research Products

出版日
ページ情報
英文 178 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
エクソソーム研究製品の世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 178 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

エクソソーム研究製品の世界市場は2030年までに13億米ドルに達する見込み

2024年に4億1,230万米ドルと推定されるエクソソーム研究製品の世界市場は、分析期間2024-2030年にCAGR 20.6%で成長し、2030年には13億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるキット・試薬は、CAGR 22.2％を記録し、分析期間終了時には6億9,780万米ドルに達すると予測されます。機器セグメントの成長率は、分析期間のCAGRで20.0％と推定されます。

米国市場は1億2,020万米ドルと推定、中国はCAGR19.8％で成長予測

米国のエクソソーム研究製品市場は、2024年に1億2,020万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを19.8%として、2030年までに1億9,330万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ18.3％と16.9％と予測されています。欧州では、ドイツがCAGR約13.7%で成長すると予測されています。

世界のエクソソーム研究製品市場- 主要動向と促進要因のまとめ

エクソソーム研究製品とは何か、なぜ重要なのか？

単離キット、精製試薬、特性評価ツールなどのエクソソーム研究製品は、エクソソーム（細胞間コミュニケーションに重要な役割を果たし、様々な生物学的プロセスに関連する小さな細胞外小胞）の研究に不可欠です。エクソソームには、親細胞のタンパク質、RNA、DNA、脂質が含まれており、がん、神経変性疾患、心血管疾患など数多くの疾患の貴重なバイオマーカーとなっています。複雑な生物学的情報を運ぶ能力を持つエクソソームは、診断、治療、ドラッグデリバリー用途の研究に幅広く利用されています。例えば腫瘍学では、エクソソームは腫瘍の挙動に関する貴重な洞察を提供し、疾患の進行や治療に対する反応をモニタリングする非侵襲的なアプローチを提供します。そのバイオマーカーとしての可能性から、エクソソームの単離、精製、解析のための信頼性の高いツールを求める研究者の間で、エクソソーム研究製品に対する需要が高まっています。

エクソソームは治療薬のキャリアーとして機能し、薬物や遺伝物質を標的細胞に送達することができるため、エクソソーム研究は再生医療や免疫療法においても重要です。エクソソームに基づくドラッグ・デリバリー・システムの利用は、特に個別化医療において、副作用を最小限に抑えた標的治療を可能にするものとして注目を集めています。エクソソームの応用が拡大するにつれ、医薬品開発と診断における発見を進めるためには、高品質で信頼性の高い研究製品が不可欠となっています。エクソソーム研究への関心の高まりは、学術機関、バイオテクノロジー企業、製薬会社からの資金提供の増加によって支えられており、エクソソーム研究は医学において急速に発展している分野です。

技術の進歩はエクソソーム研究をどのように強化しているのか？

技術の進歩はエクソソーム研究を大きく変え、これらの小胞の単離、特性解析、分析をより効率的で正確なものにしています。エクソソーム研究の重要な課題のひとつは、エクソソームの正確で再現性のある単離です。なぜなら、エクソソームは小さく、しばしば生体液中に低濃度で存在するからです。超遠心分離、免疫親和性捕捉、マイクロ流体などの分離技術における最近の技術革新は、プロセスを合理化し、研究者が高純度のエクソソームサンプルを得ることを可能にしました。これらの進歩は、研究の質を向上させるだけでなく、分子プロファイリングや治療開発といった下流の応用において、より信頼性の高いデータを可能にします。さらに、次世代シークエンシング（NGS）とプロテオミクスの開発により、エクソソームの含有量を詳細に分析する能力が向上し、研究者は疾患の早期発見のための特定のバイオマーカーを同定できるようになりました。

さらに、人工知能（AI）と機械学習（ML）を組み合わせたハイスループットスクリーニング技術により、大規模なエクソソームデータセットの迅速な解析が可能となっています。これらのツールは、新規バイオマーカーの発見とエクソソームに基づく診断検査の開発を促進し、精密医療の進歩を加速します。フローサイトメトリー、ナノ粒子追跡分析（NTA）、電子顕微鏡の進歩により、エクソソームの特性評価も大幅に改善され、研究者は粒子径、濃度、分子組成をかつてない精度で分析できるようになりました。これらの技術的な飛躍的進歩が相まって、エクソソーム研究製品の機能が拡大し、科学者は診断、治療、ドラッグデリバリーにおけるエクソソームの可能性を最大限に引き出すことができます。

なぜエクソソーム研究の新たな応用が生まれているのか？

エクソソームの多用途性により、診断からドラッグデリバリー、さらにはワクチン開発まで、エクソソームの応用分野が拡大しています。診断学では、エクソソームは、がん、神経変性疾患、心血管疾患など、さまざまな疾患に対する貴重な非侵襲的バイオマーカーであることが証明されつつあります。エクソソームは血液や尿など、容易に入手できる体液から得ることができるため、従来の生検に代わる有望な選択肢となり、病気の進行や治療反応をリアルタイムでモニタリングすることが可能になります。このようなリキッドバイオプシー応用の可能性から、製薬会社や研究機関は、病気の早期発見を向上させる効率的で非侵襲的な診断検査の開発を期待し、エクソソーム研究製品への投資を促しています。

製薬業界はまた、エクソソームの自然な生体適合性と血液脳関門のような生物学的障壁を通過する能力から、ドラッグデリバリー・ビークルとしての利用も模索しています。この特性により、エクソソームは、神経疾患の治療において、脳のような到達しにくい部位に薬剤を送達するために特に有用です。さらに、エクソソームに基づく治療法は再生医療でも注目されており、標的細胞に成長因子を送達することで組織の修復や創傷治癒を促進するために用いられています。ワクチン開発もまた新たな分野であり、エクソソームは免疫反応調節における抗原のキャリアとして試験されています。このように複数の医療分野で用途が拡大していることから、治療・診断目的のエクソソームの単離、改変、機能解析をサポートする専門的なエクソソーム研究製品に対する需要が高まっています。

世界のエクソソーム研究製品市場の成長を牽引しているのは？

エクソソーム研究製品市場の成長は、技術革新、エクソソームの応用範囲の拡大、生物医学研究への投資の増加に根ざしたいくつかの要因によって牽引されています。エクソソームの分離と特性評価ツールの技術的進歩により、エクソソーム研究の精度と効率が大幅に向上し、バイオマーカー探索や治療デリバリーなどの高感度アプリケーションでの使用が可能になりました。エクソソームの診断および治療用途が拡大し続ける中、製薬企業やバイオテクノロジー企業は、特にがん診断、神経変性疾患、再生治療などのエクソソームベースの製品開発に多額の投資を行っています。これらの要因により、エクソソームの分離、分析、改変を容易にする高品質の研究用製品に対する需要が高まっています。さらに、個別化医療の台頭と非侵襲的診断ツールに対する需要は、エクソソームが疾患モニタリングとドラッグデリバリーのための低侵襲的選択肢を提供することから、市場成長の主な促進要因となっています。官民両部門からの資金提供の増加も市場を加速させています。これは、医療機関が未充足の医療ニーズに対応するエクソソーム研究の可能性を認識しているためです。エクソソームをベースとした治療薬の開発や、エクソソームをワクチン送達に活用することへの関心の高まりは、特殊な研究製品への需要をさらに高めています。これらの要因を総合すると、エクソソーム研究はライフサイエンスにおける重要な分野として位置づけられ、エクソソーム分離キット、特性評価ツール、分析技術市場の持続的成長を支えています。

セグメント

コンポーネント（キット・試薬、機器、サービス）、用途（肺がん、乳がん、前立腺がん、大腸がん、その他の用途）、最終用途（学術・研究機関、製薬・バイオテクノロジー企業、病院・臨床検査機関）

調査対象企業の例

  • AMS Biotechnology Ltd.
  • Bio-Techne
  • Lonza Group AG
  • Miltenyi Biotech
  • Nanosomix
  • Norgen Biotek Corp.
  • NX Pharmagen
  • Qiagen N.V.
  • System Biosciences（SBI）
  • Thermo Fisher Scientific Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP21745

Global Exosome Research Products Market to Reach US$1.3 Billion by 2030

The global market for Exosome Research Products estimated at US$412.3 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 20.6% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by the end of the analysis period. Growth in the Instruments segment is estimated at 20.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$120.2 Million While China is Forecast to Grow at 19.8% CAGR

The Exosome Research Products market in the U.S. is estimated at US$120.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$193.3 Million by the year 2030 trailing a CAGR of 19.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.3% and 16.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.7% CAGR.

Global Exosome Research Products Market - Key Trends & Drivers Summarized

What Are Exosome Research Products and Why Are They Important?

Exosome research products, including isolation kits, purification reagents, and characterization tools, are essential in studying exosomes-small extracellular vesicles that play a critical role in cell-to-cell communication and are linked to a variety of biological processes. Exosomes contain proteins, RNA, DNA, and lipids from their parent cells, making them valuable biomarkers for numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. With their ability to carry complex biological information, exosomes are used extensively in research for diagnostics, therapeutics, and drug delivery applications. For instance, in oncology, exosomes provide valuable insights into tumor behavior and offer a non-invasive approach to monitoring disease progression and response to treatments. Their potential as biomarkers has led to an increasing demand for exosome research products, as researchers seek reliable tools for exosome isolation, purification, and analysis.

Exosome research is also critical in regenerative medicine and immunotherapy, as exosomes can serve as carriers for therapeutic agents, delivering drugs or genetic material to targeted cells. The use of exosome-based drug delivery systems is gaining traction, especially in personalized medicine, where they enable targeted treatment with minimal side effects. As exosome applications expand, high-quality, reliable research products are crucial for advancing discoveries in drug development and diagnostics. The growing interest in exosome research is supported by increased funding from academic institutions, biotechnology firms, and pharmaceutical companies, making exosome research products a rapidly evolving field in medical science.

How Are Technological Advancements Enhancing Exosome Research?

Technological advancements have significantly transformed exosome research, making the isolation, characterization, and analysis of these vesicles more efficient and precise. One of the critical challenges in exosome research is the accurate and reproducible isolation of exosomes, as they are small and often found in low concentrations in biological fluids. Recent innovations in isolation techniques, such as ultracentrifugation, immunoaffinity capture, and microfluidics, have streamlined the process, enabling researchers to obtain high-purity exosome samples. These advancements not only improve the quality of research but also allow for more reliable data in downstream applications like molecular profiling and therapeutic development. Additionally, developments in next-generation sequencing (NGS) and proteomics have enhanced the ability to analyze exosomal content in detail, enabling researchers to identify specific biomarkers for early disease detection.

Furthermore, high-throughput screening technologies, combined with artificial intelligence (AI) and machine learning (ML), are enabling rapid analysis of large exosome datasets. These tools facilitate the discovery of novel biomarkers and the development of exosome-based diagnostic tests, accelerating progress in precision medicine. Advancements in flow cytometry, nanoparticle tracking analysis (NTA), and electron microscopy have also significantly improved exosome characterization, allowing researchers to analyze particle size, concentration, and molecular composition with unprecedented accuracy. Together, these technological breakthroughs are expanding the capabilities of exosome research products, allowing scientists to unlock the full potential of exosomes in diagnostics, therapeutics, and drug delivery.

Why Are New Applications for Exosome Research Emerging?

The versatility of exosomes is driving their adoption in an increasing number of applications, from diagnostics to drug delivery and even vaccine development. In diagnostics, exosomes are proving to be valuable non-invasive biomarkers for a variety of conditions, including cancer, neurodegenerative diseases, and cardiovascular disorders. Since exosomes can be obtained from easily accessible bodily fluids, such as blood and urine, they offer a promising alternative to traditional biopsies, allowing for real-time monitoring of disease progression and treatment response. This potential for liquid biopsy applications is encouraging pharmaceutical companies and research institutions to invest in exosome research products, hoping to develop efficient, non-invasive diagnostic tests that improve early disease detection.

The pharmaceutical industry is also exploring the use of exosomes as drug delivery vehicles due to their natural biocompatibility and ability to cross biological barriers, such as the blood-brain barrier. This property makes exosomes particularly valuable for delivering drugs to hard-to-reach areas, such as the brain, in treating neurological diseases. Additionally, exosome-based therapies are gaining attention in regenerative medicine, where they are used to promote tissue repair and wound healing by delivering growth factors to target cells. Vaccine development is yet another emerging area, with exosomes being tested as carriers for antigens in immune response modulation. These expanding applications across multiple medical fields highlight the growing demand for specialized exosome research products that support the isolation, modification, and functional analysis of exosomes for therapeutic and diagnostic purposes.

What’s Driving the Growth of the Global Exosome Research Products Market?

The growth in the exosome research products market is driven by several factors, rooted in technological innovation, the expanding scope of exosome applications, and increasing investment in biomedical research. Technological advancements in exosome isolation and characterization tools have significantly improved the precision and efficiency of exosome research, enabling their use in highly sensitive applications such as biomarker discovery and therapeutic delivery. As diagnostic and therapeutic applications for exosomes continue to expand, pharmaceutical and biotech companies are heavily investing in the development of exosome-based products, particularly for cancer diagnostics, neurodegenerative diseases, and regenerative therapies. These factors are propelling demand for high-quality research products that facilitate the isolation, analysis, and modification of exosomes. Additionally, the rise of personalized medicine and the demand for non-invasive diagnostic tools are major drivers of market growth, as exosomes offer a minimally invasive option for disease monitoring and drug delivery. Increased funding from both public and private sectors is also accelerating the market, as institutions recognize the potential of exosome research in addressing unmet medical needs. The development of exosome-based therapeutics and the growing interest in leveraging exosomes for vaccine delivery further contribute to the demand for specialized research products. Collectively, these factors are positioning exosome research as a critical field within life sciences, supporting sustained growth in the market for exosome isolation kits, characterization tools, and analytical technologies.

SCOPE OF STUDY:

The report analyzes the Exosome Research Products market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Kits & Reagents, Instruments, Services); Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other Applications); End-Use (Academic & Research Institutes, Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • AMS Biotechnology Ltd.
  • Bio-Techne
  • Lonza Group AG
  • Miltenyi Biotech
  • Nanosomix
  • Norgen Biotek Corp.
  • NX Pharmagen
  • Qiagen N.V.
  • System Biosciences (SBI)
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Exosome Research Products - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Interest in Exosome-Based Diagnostics and Therapeutics Drives Growth in Exosome Research Products and Technologies
    • Increased Focus on Cancer Research Expands Demand for Exosome Products as Biomarkers for Early Detection and Monitoring
    • Advances in Exosome Isolation and Purification Technologies Improve Accuracy, Supporting Growth in Research Applications
    • Growing Investment in Regenerative Medicine Fuels Demand for Exosome Products in Cell Therapy and Tissue Engineering
    • Expansion of Precision Medicine Drives Demand for Exosome Products in Personalized Drug Delivery Solutions
    • Increased Adoption of Exosome-Based Liquid Biopsies Expands Applications in Non-Invasive Cancer Screening
    • Technological Advancements in Exosome Characterization Tools Enhance Research Capabilities for Drug Development
    • Rising Demand for Exosome Products in Neurological Disorders Supports Research in Brain and CNS Therapeutics
    • Growing Interest in Exosome-Based Vaccine Development Fuels Demand for High-Quality Exosome Research Products
    • Increasing Research Funding for Extracellular Vesicle (EV) Studies Drives Demand for Exosome Isolation Kits and Reagents
    • Expansion of Exosome Research in Cardiovascular and Autoimmune Diseases Supports Development of Targeted Therapies
    • Advances in Microfluidic and Nanotechnology-Based Exosome Isolation Methods Enhance Precision and Efficiency
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinical Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Hospitals & Clinical Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Colorectal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Colorectal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 25: World Exosome Research Products Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • CHINA
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030

IV. COMPETITION